Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CALIFORNIA PROPOSAL THAT WOULD EFFECTIVELY BAN UNDERARM AEROSOLS

Executive Summary

CALIFORNIA PROPOSAL THAT WOULD EFFECTIVELY BAN UNDERARM AEROSOLS was discussed at a June 25 meeting between the California Air Resources Board (CARB) and industry representatives including the Cosmetic, Toiletry and Fragrance Assn. (CTFA) and the Chemical Specialties Mfrs. Assn. (CSMA). In response to the proposal, CTFA and CSMA announced that they are funding a study on its economic impact. Industry groups also said they plan to file a joint memo responding to the CARB proposal before July 17. On May 16, CARB proposed rules that would limit the photochemically reactive organic compounds (PROCs) in aerosol antiperspirants and deodorants to 2% by weight. Based on calculations made in conjunction with CSMA, the CARB staff estimated that the total average PROCs present in aerosol antiperspirants is 75%, and in aerosol deodorants, 95%. The PROCs in underarm products include propellants, solvents and fragrances. California represents approximately 10% of the domestic antiperspirant/deodorant market, according to CARB's draft proposal. The underarm aerosol product restriction would be part of an overall effort by regulatory agencies in California to provide a "menu" of control measures for use by local districts in adopting regs to meet ambient air quality standards. The state restriction would apply to all underarm products, including pump sprays, sticks, roll-ons, creams, pads and plastic squeeze-bottles, although current estimates for non-aerosols indicate far lower PROC levels than those in aerosols. For example, stick deodorants contain from 0-43%, and stick antiperspirants contain 0-13% PROCs, the report says. The CARB staff is also planning to develop control measures for hair sprays and other household products. CTFA noted that industry is requesting the CARB staff to delay making final recommendations to the full board until industry submits new data. CTFA said it expects CARB to redraft the proposal and perhaps meet with industry representatives again before presenting a revised draft to a CARB technical review panel, which will decide whether to send the proposal to the full board.

You may also be interested in...



Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance

FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials

Shire Hopes To Sow Future Deals With $50M Venture Fund

Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth

Latest Headlines
See All
UsernamePublicRestriction

Register

PS010398

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel